In addition to high CD86 expression on B cells, Castleman et al. (86) found high levels of the activation molecule CD69 on CD19+ B cells in COVID-19 convalescents, who were also noted to have a greater percentage of memory B cells compared to acute COVID-19 [I. V. (66)]. Here, CD86 is linked to COVID-19.